Skip to content

Clinical trials

Phase 2 Nervous System Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 2 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20132
20151
20181
20221
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Completed3
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MapLight Therapeutics2
Affiris AG1
Alkahest, Inc.1
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier de PAU1
GenSight Biologics1
GlaxoSmithKline1
Inmune Bio, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases10
Brain Diseases6
Dementia6
Mental Disorders6
Neurodegenerative Diseases6
Alzheimer Disease5
Central Nervous System Diseases5
Neurocognitive Disorders4
Tauopathies4
Hallucinations2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.